Robinson Value Management Ltd. Sells 459 Shares of CVS Health Co. (NYSE:CVS)

Robinson Value Management Ltd. decreased its stake in shares of CVS Health Co. (NYSE:CVS) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,552 shares of the pharmacy operator’s stock after selling 459 shares during the period. Robinson Value Management Ltd.’s holdings in CVS Health were worth $1,921,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Steph & Co. grew its position in CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. Crewe Advisors LLC bought a new position in CVS Health in the first quarter valued at $40,000. Retirement Group LLC grew its position in CVS Health by 54.3% in the first quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 182 shares in the last quarter. Kathleen S. Wright Associates Inc. bought a new position in CVS Health in the third quarter valued at $33,000. Finally, First Community Trust NA grew its position in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Evercore ISI boosted their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Barclays upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $63.00 to $82.00 in a research note on Thursday, October 10th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Wells Fargo & Company boosted their price objective on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Finally, TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.26.

CVS Health Price Performance

Shares of CVS Health stock traded down $1.40 on Monday, reaching $58.94. 4,578,577 shares of the stock were exchanged, compared to its average volume of 11,195,618. The firm’s 50 day moving average is $59.80 and its 200-day moving average is $60.43. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The firm has a market cap of $73.99 billion, a PE ratio of 10.60, a P/E/G ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter in the prior year, the firm posted $2.21 EPS. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. As a group, analysts anticipate that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.51%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.